(Q37280933)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821433%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

review article

1 reference

title

Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821433%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821433%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Emanuele Zucca

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821433%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

3

Michael Pfreundschuh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821433%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Christian Gisselbrecht

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821433%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821433%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821433%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

49 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821433%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

52-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821433%20AND%20SRC:MED&resulttype=core&format=json

Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Secondary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Prevention and treatment of central nervous system involvement by non-Hodgkin's lymphoma: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

CNS prophylaxis and treatment in non-Hodgkin's lymphoma: variation in practice and lessons from the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Central nervous system involvement in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

CNS involvement in primary mediastinal large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

CNS prophylaxis in lymphoma: who to target and what therapy to use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Primary breast lymphoma: results of a controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Non-Hodgkin lymphoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802311458

10.1080/10428190802311458

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18821433%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference